Antoniou Antony

Dr. Antoniou Antony

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DLDongtao Ni Li
Dongtao Ni Li
SMStephen P. Matthews
Stephen P. Matthews
AAAntoniou Antony
Antoniou Antony
DMDaniela Mazzeo
Daniela Mazzeo
CWColin Watts
Colin Watts
Mammalian asparaginyl endopeptidase (AEP) or legumain is a recently discovered lysosomal cysteine protease that specifically cleaves after asparagine residues. How this unusually specific lysosomal protease is itself activated is not fully understood. Using purified recombinant pro-enzyme, we show that activation is autocatalytic, requires sequential removal of C- and N-terminal pro-peptides at different pH thresholds, and is bimolecular. Removal of the N-terminal propeptide requires cleavage after aspartic acid rather than asparagine. Cellular processing, either of exogenously added AEP precursor or of pulse-labeled endogenous precursor, introduces at least one further cleavage to yield the final mature lysosomal enzyme. We also provide evidence that in living cells, there is clear compartmental heterogeneity in terms of AEP activation status. Moreover, we show that human monocyte-derived dendritic cells harbor inactive proforms of AEP that become activated upon maturation of dendritic cells with lipopolysaccharide.

1 April 2000 in Immunity
Verified
Journal Article
Closed access
AAAntoniou Antony
Antoniou Antony
SBSarah-Louise Blackwood
Sarah-Louise Blackwood
DMDaniela Mazzeo
Daniela Mazzeo
CWColin Watts
Colin Watts

1 February 1999 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JCJian-Guo Chai
Jian-Guo Chai
IBIstvan Bartok
Istvan Bartok
PCPhillip Chandler
Phillip Chandler
SVSilvia Vendetti
Silvia Vendetti
AAAntoniou Antony
Antoniou Antony
RLRobert Lechler
Robert Lechler
The potential suppressive effects of allospecific anergic T cells were investigated both in vitro and in vivo. Allospecific T cells were rendered unresponsive in vitro using immobilized anti‐CD3 mAb. These anergic T cells profoundly inhibited proliferation of responsive T cells in an antigen‐specific manner. The observed inhibition did not appear to be due to the release of inhibitory cytokines in that secretion of IL‐2, IFN‐γ, IL‐4, IL‐10 and TGF‐β was greatly reduced following the induction of anergy, and neutralizig mAb specific for IL‐4, IL‐10 and TGF‐β failed to reverse the inhibition. Furthermore, the suppression mediated by anergic T cells required cell to cell contact. In vivo, adoptive transfer of anergic T cells into recipients of allogeneic skin grafts led to prolonged skin graft survival. Consistent with the lack of inhibitory cytokine production by the anergic cells, prolongation of skin allograft rejection was not influenced by the simultaneous administration of a neutralizing anti‐IL‐4 antibody. These results indicate that anergic T cells can function as antigen‐specific suppressor cells both in vitro and in vivo.

8 October 2009 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CHChristopher Howe
Christopher Howe
MGMalgorzata Anna Garstka
Malgorzata Anna Garstka
MAMohammed Al‐Balushi
Mohammed Al‐Balushi
EGEsther Ghanem
Esther Ghanem
AAAntoniou Antony
Antoniou Antony
SSSebastian Springer
Sebastian Springer
Calreticulin is a lectin chaperone of the endoplasmic reticulum (ER). In calreticulin‐deficient cells, major histocompatibility complex (MHC) class I molecules travel to the cell surface in association with a sub‐optimal peptide load. Here, we show that calreticulin exits the ER to accumulate in the ER–Golgi intermediate compartment (ERGIC) and the cis ‐Golgi, together with sub‐optimally loaded class I molecules. Calreticulin that lacks its C‐terminal KDEL retrieval sequence assembles with the peptide‐loading complex but neither retrieves sub‐optimally loaded class I molecules from the cis ‐Golgi to the ER, nor supports optimal peptide loading. Our study, to the best of our knowledge, demonstrates for the first time a functional role of intracellular transport in the optimal loading of MHC class I molecules with antigenic peptide.

1 February 2003 in Current Opinion in Immunology
Verified
Journal Article
Closed access
AAAntoniou Antony
Antoniou Antony
SPSimon J Powis
Simon J Powis
TETim Elliott
Tim Elliott

1 March 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AAAntoniou Antony
Antoniou Antony
SFStuart Ford
Stuart Ford
JTJoel D. Taurog
Joel D. Taurog
GBGeoffrey W. Butcher
Geoffrey W. Butcher
SPSimon J. Powis
Simon J. Powis
The human HLA-B27 class I molecule exhibits a strong association with the inflammatory arthritic disorder ankylosing spondylitis and other related arthropathies. Major histocompatibility complex class I heavy chains normally associate with beta(2)-microglobulin and peptide in the endoplasmic reticulum before transit to the cell surface. However, an unusual characteristic of HLA-B27 is its ability to form heavy chain homodimers through an unpaired cysteine at position 67 in the peptide groove. Homodimers have previously been detected within the ER and at the cell surface, but their mechanism of formation and role in disease remain undefined. Here we demonstrate, in the rat C58 thymoma cell line and in human HeLa cells transfected with HLA-B27, that homodimer formation involves not only cysteine at position 67 but also the conserved structural cysteine at position 164. We also show that homodimer formation can be induced in the non-disease-associated HLA class I allele HLA-A2 by slowing its assembly rate by incubation of cells at 26 degrees C, suggesting that homodimer formation in the endoplasmic reticulum may occur as a result of the slower folding kinetics of HLA-B27. Finally, we report an association between unfolded HLA-B27 molecules and immunoglobulin-binding protein at the cell surface.